Finance

Lists
ALMS:NASDAQ
Alumis Inc
$9.16
-58.02%
(-12.66) 1D
Sep 1, 1:46:17 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALMS...
Open
$9.93
High
$11.06
Low
$8.75
Mkt. cap
1.18B
Avg. vol.
883.54K
Volume
19.47M
52-wk high
$31.35
52-wk low
$3.76
EPS
-$3.81
Shares outstanding
129.44M
No. of employees
238
Open
$9.93
High
$11.06
Low
$8.75
Mkt. cap
1.18B
Avg. vol.
883.54K
Volume
19.47M
52-wk high
$31.35
52-wk low
$3.76
EPS
-$3.81
Shares outstanding
129.44M
No. of employees
238
News stories
From web sources and news partners
About Alumis Inc
CEO-
Employees238
Founded2021
HeadquartersSouth San Francisco, California, United States
SectorPharmaceutical industry
Websitealumis.com
Analyst ratings
Based on 6 analysts giving stock ratings to ALMS in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ALMS in the last 3 months.
Highest
Current $9.16
$55.00 (+500.76%)
Average
$41.33 (+351.45%)
Lowest
$25.00 (+173.07%)
Analyst
Recommendation
Action
Price target
Projected
Date
Terence Flynn
Morgan Stanley
Buy
Reiterated
$39.00
+326%
08/17/2026
Ari Wald
Oppenheimer
Buy
Maintained
$55.00
+500.8%
08/14/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$34.00
+271.4%
08/13/2026
Derek Archila
Wells Fargo
Buy
Reiterated
$51.00
+457.1%
08/14/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
$44.00
+380.6%
08/13/2026
Mitchell Kapoor
H.C. Wainwright
Hold
Reiterated
$25.00
+173.1%
08/11/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
$55.00
+500.8%
07/15/2026
Janani Sundararajan
Chardan Capital
Buy
Reiterated
$40.00
+336.9%
05/19/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
$32.00
+249.5%
05/15/2026
Christopher Raymond
Raymond James
Buy
Maintained
$46.00
+402.5%
03/27/2026
Last report
Aug 13, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.79 / -$0.71
-11.30%miss
Revenue / Est. (USD)
1.66M / 2.12M
-21.79%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.07M
1.93M
1.74M
1.66M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
95.44M
83.48M
81.54M
85.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.62M
16.19M
18.61M
23.36M
Operating expense
113.06M
99.67M
100.15M
108.69M
Total operating expenses
113.06M
99.67M
100.15M
108.69M
Operating income
-110.99M
-97.74M
-98.41M
-107.03M
Other non operating income
-54.00K
-33.00K
7.00K
-71.00K
EBT including unusual items
-110.75M
-92.93M
-93.05M
-143.98M
EBT excluding unusual items
-106.45M
-94.23M
-93.05M
-102.15M
Income tax expense
-
-
-
-1.76M
Effective tax rate
-
-
-
1.22%
Other operating expenses
-
-
-
-
Net income
-110.75M
-92.93M
-93.05M
-142.22M
Net profit margin
-5,360.70%
-4,817.57%
-5,344.80%
-8,557.22%
Earnings per share
-1.06
-0.25
-0.74
-0.79
Interest and investment income
4.59M
3.55M
5.35M
4.95M
Interest expense
-
-
-
-
Net interest expenses
4.59M
3.55M
5.35M
4.95M
Depreciation and amortization charges
-
-
-
-
EBITDA
-110.08M
-96.88M
-97.54M
-106.16M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps